Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR4-NOT transcription complex subunit 7 (CNOT7) is a highly conserved enzyme that forms part of the multi-subunit CCR4-NOT deadenylase complex, which is the major cytoplasmic machinery responsible for deadenylation—removal of the poly(A) tail from mRNA transcripts, leading to mRNA decay and regulation of gene expression[1][2][4]. CNOT7 possesses 3'-5' poly(A) exoribonuclease activity and works in concert with related subunits such as CNOT8, showing partial functional redundancy[6]. The protein also participates in transcriptional regulatory events: it suppresses or potentiates transcription of specific genes, in part by interacting with nuclear hormone receptors (e.g., estrogen and retinoic acid receptors) and members of the BTG/Tob family of cell cycle regulatory proteins[2][3][4][5]. CNOT7 is essential for cell proliferation and viability in mammalian cells, with roles in mRNA turnover, cell cycle progression, and possibly in immune and metabolic function. Loss of CNOT7 in mice results in male infertility and altered bone formation but is otherwise compatible with life, highlighting tissue-specific dependencies[3][4]. No drugs are currently approved to directly target CNOT7, and its central function in mRNA biology and gene regulation suggests that indiscriminate inhibition could result in broad and severe phenotypic effects.
Not targeted by approved drugs; as an endogenous enzyme, functions by enzymatic removal of poly(A) tails from mRNA substrates, regulating transcript stability and gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCR4-NOT transcription complex subunit 7 (CNOT7).